MASSDEVICE ON CALL — Bad timing and a financial crisis nearly buried MVRx and its mitral valve repair technology forever, but the company’s founders finally revealed their progress over the weekend at the Transcatheter Cardiovascular Therapeutics conference.
Founded by a cardiovascular surgeon and a group of medtech industry veterans, MVRx was born in a garage in San Francisco in 2002. The team shelved the product for some time in response to the the 2008 financial meltdown and other circumstances, but they’re ready to unveil their novel device on a global stage.
"We truly believe that our technology is the safest and most efficacious way to improve the lives of heart failure patients suffering from mitral valve regurgitation," co-founder Robert Chang said in prepared remarks. "Reaching this important milestone is a testament to the determination and perseverance of the team. We look forward to helping many more patients in the future."
The company presented the results from its latest human trials during the 2014 TCT conference in Washington, D.C.
Baxano sets up Arizona training spree
Baxano Surgical (NSDQ:BAXS) is preparing to train 35 surgeons in minimally invasive surgical techniques during a 2-day course in Phoenix, Ariz.
Read more
Nearly half of employees will offer telehealth next year
A survey of employers found that 48% plan to offer their employees telehealth services next year, accounting for about 7.5 million workers.
Read more
Google buys Parkinson’s spoons
Tech titan Google (NSDQ:GOOG) announced that it’s buying Life Labs, makers of stabilized utensils to help cancel out tremors and help patients with Parkinson’s eat more easily.
Read more
Medtronic celebrates 40 years in Puerto Rico
Medtronic (NYSE:MDT) celebrated the 40th anniversary of its presence in Puerto Rico, saying that it has big plans for its future in the country.
Read more
